Antithrombotic treatment before and after peripheral artery percutaneous angioplasty

Blood Transfus. 2009 Jan;7(1):18-23. doi: 10.2450/2008.0008-08b.
No abstract available

Publication types

  • Review

MeSH terms

  • Abciximab
  • Angioplasty, Balloon, Coronary* / rehabilitation
  • Antibodies, Monoclonal / therapeutic use
  • Aspirin / therapeutic use
  • Coronary Restenosis / prevention & control*
  • Dipyridamole / therapeutic use
  • Drug Combinations
  • Fibrinolytic Agents / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Pyridines / therapeutic use
  • Randomized Controlled Trials as Topic
  • Thrombolytic Therapy*

Substances

  • Antibodies, Monoclonal
  • Drug Combinations
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Pyridines
  • thienopyridine
  • Dipyridamole
  • Aspirin
  • Abciximab